Physician profile
Toby Marshall
NPI 1861400863
$9,342.14
in general payments reported to CMS, 2019-2025
19 companies · $6,256 in 2025
The $6,256 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $402 · 2022: $344 · 2023: $615 · 2024: $1,725 · 2025: $6,256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,519 · Travel and Lodging: $3,259 · Food and Beverage: $817.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,519.27 |
| Travel and Lodging | $3,259.08 |
| Food and Beverage | $817.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,064.05 | 2025 | |
| Axonics, INC. | $2,187.34 | 2023-2024 | Axonics, Bulkamid |
| Medical Device Business Services, INC. | $325.00 | 2021 | |
| Boston Scientific Corporation | $191.76 | 2025 | Axonics |
| Abbvie INC. | $103.47 | 2021-2022 | |
| Hologic Sales and Service, LLC | $99.07 | 2021-2023 | Omni Hysteroscope, Novasure, Coolseal Generator |
| Organon LLC | $64.82 | 2021-2023 | Nexplanon |
| Pfizer INC. | $56.39 | 2022 | |
| Asensus Surgical, INC. | $37.34 | 2022 | |
| Exeltis, USA INC. | $35.48 | 2023-2024 | Slynd |
| Therapeuticsmd, INC. | $33.77 | 2022 | |
| Avion Pharmaceuticals | $26.91 | 2022 | |
| Smith+Nephew, INC. | $25.94 | 2022 | |
| Sumitomo Pharma America, INC. | $19.27 | 2023 | Myfembree |
| Coopersurgical, INC. | $17.28 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $14.84 | 2022 | |
| Mayne Pharma Commercial LLC | $14.14 | 2022 | |
| Amgen INC. | $12.86 | 2022 | |
| Myovant Sciences INC. | $12.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Toby Marshall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.